Skip to content

NUTRAPHAR BE

Active
Private limited companyfounded 20242 yrs activeAvenue Baudouin de Changy 4, 1380 Lasne, BelgiumKBO/BCE: BE 1012.754.333
Summary

The computed 12-month bankruptcy probability of NUTRAPHAR BE is 4.2% (elevated). The 2025 annual accounts show negative equity (-€2,910) and a net result of -€7,910. Its solvency ranks better than 16% of 60 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes
Profitability0
Solvency0
Growth-
Track record67
Bankruptcy probability, 12 months
4.2% Elevated
0%0.5%1.5%4%10%≥ 25%
No credit on open account
balance sheet total too small for a liquidity verdict, and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Age of the figures
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21)
about 14% more bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-08-2026, 12 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
12 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

NUTRAPHAR BE was incorporated on 23 August 2024 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
-€2,910
Total assets
€1,779
Net result
-€7,910
Working capital
-€2,910

Turnover and EBIT margin not published: the micro schema does not require them.

Key figures and ratios
2025 value
Debt
€4,689
Debt ≤ 1 year
€4,689
Ratios withheld: a balance sheet total of €1,779 is too small for a meaningful ratio.

Peer companies

Historical observation

Of the 7,638 companies that looked in July 2024 the way this one looks now, 8.9% went bankrupt within 24 months and 85% are still going.

  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
8.9% went bankrupt
5.6% stopped otherwise
85% still going

A further 0.7% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 4.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 7,638 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 23 lines
Balance sheet Code2025
Assets
Total assets20/58€1,779
Current assets29/58€1,779
Amounts receivable within one year40/41€688
Other amounts receivable41€688
Cash at bank and in hand54/58€1,091
Equity and liabilities
Total equity and liabilities10/49€1,779
Equity10/15-€2,910
Contributions10/11€5,000
Profit (loss) carried forward14-€7,910
Amounts payable17/49€4,689
Amounts payable within one year42/48€4,689
Trade debts44€295
Suppliers440/4€295
Other amounts payable47/48€4,394
Income statement Code2025
Other operating charges640/8€387
Gross operating margin9900-€7,450
Operating profit (loss)9901-€7,838
Financial charges65/66B€72
Recurring financial charges65€72
Profit (loss) for the period before taxes9903-€7,910
Profit (loss) for the period9904-€7,910
Profit (loss) for the period to be appropriated9905-€7,910
Appropriation of the result
Profit (loss) to be appropriated9906-€7,910

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Other operating charges640/8€387
Gross operating margin9900-€7,450
Operating profit (loss)9901-€7,838
Financial charges65/66B€72
Recurring financial charges65€72
Profit (loss) for the period before taxes9903-€7,910
Profit (loss) for the period9904-€7,910
Profit (loss) for the period to be appropriated9905-€7,910
Line2025
Assets
Total assets20/58€1,779
Current assets29/58€1,779
Amounts receivable within one year40/41€688
Other amounts receivable41€688
Cash at bank and in hand54/58€1,091
Equity and liabilities
Total equity and liabilities10/49€1,779
Equity10/15-€2,910
Contributions10/11€5,000
Profit (loss) carried forward14-€7,910
Amounts payable17/49€4,689
Amounts payable within one year42/48€4,689
Trade debts44€295
Suppliers440/4€295
Other amounts payable47/48€4,394
Line2025
Profit (loss) for the period9904-€7,910
Operating cash flow (approximation)-€7,910

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
12-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 12 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 1 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Lasne · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
5,456 m²
Building footprint
203 m²
Volume, LiDAR
891 m³
Parcel 25051G0057/00B002, Wallonia · tallest building 6.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
NUTRAPHAR BE
Avenue Baudouin de Changy 4, 1380 LasneManufacture of food products
since 20242.363.310.572
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
25051G0057/00B002 Wallonia 5,456 m² 1 · 203 m² 6.3 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Lasne2.363.310.572
1 permission
Groothandelaar LM>3 maand · since 27-11-2025

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 97 companies in this sector we hold annual accounts for 74. See the whole sector

Company details

Identification
Legal formPrivate limited company
Founded23-08-2024
Fiscal year end31-12
Activities, NACEBEL 2025
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
10890Manufacture of food products
46389Wholesale of other food products
46460Wholesale of pharmaceutical and medical goods
Contact
E-mail phaverbeke@nutraphar.chLasne
E-invoicing
Reachable via Peppol
Peppol ID 0208:1012754333
Registered 06-01-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.